Similar stories
3 outlets
See how this story developed, hour by hour
Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
finance.yahoo.com
23.08.2026
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
19.08.2026
Moderna share price doubles on melanoma vaccine trial success
ft.com
19.08.2026